Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults
ConditionLiver Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-75
SponsorPusan National University Yangsan Hospital
About this trial
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Eligibility criteria
Qualifiers
ALT ranging from upper limit of reference to three times of upper limit
Disqualifiers
Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
History of viral hepatitis or cancer
Uncontrolled hypertension
Trial design
Treatments tested in this trial
- Panax Ginseng C.A. Mey Extract group
- Placebo group
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov